These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19885720)

  • 1. Synthesis and biological activity of oxytocin analogues containing unnatural amino acids in position 9: structure activity study.
    Magafa V; Borovicková L; Slaninová J; Cordopatis P
    Amino Acids; 2010 May; 38(5):1549-59. PubMed ID: 19885720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7.
    Fragiadaki M; Magafa V; Borovicková L; Slaninová J; Cordopatis P
    Eur J Med Chem; 2007 Jun; 42(6):799-806. PubMed ID: 17316912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
    Flouret G; Chaloin O; Slaninová J
    J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogues of oxytocin antagonists bearing a ureido group in the amino acid side chain at position 4 or 5.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 May; 12(5):347-53. PubMed ID: 16285023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
    Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
    Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
    Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
    J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In position 7 L- and D-Tic-substituted oxytocin and deamino oxytocin: NMR study and conformational insights.
    Spyranti Z; Fragiadaki M; Magafa V; Borovickova L; Spyroulias GA; Cordopatis P; Slaninova J
    Amino Acids; 2010 Jul; 39(2):539-48. PubMed ID: 20108008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.
    Stoev S; Cheng LL; Olma A; Klis WA; Manning M; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1999 Mar; 5(3):141-53. PubMed ID: 10323558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
    Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
    Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
    J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin analogues with amide groups substituted by tetrazole groups in position 4, 5 or 9.
    Manturewicz M; Grzonka Z; Borovicková L; Slaninová J
    Acta Biochim Pol; 2007; 54(4):805-11. PubMed ID: 18084651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity.
    Smith DD; Saha S; Fang G; Schaffert C; Waugh DJ; Zeng W; Toth G; Hulce M; Abel PW
    J Med Chem; 2003 Jun; 46(12):2427-35. PubMed ID: 12773046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of oxytocin analogues containing L-alpha-t-butylglycine [Gly(Bu t)] in positions 8 or 9.
    Fragiadaki M; Magafa V; Slaninová J; Cordopatis P
    Peptides; 2003 Sep; 24(9):1425-31. PubMed ID: 14706558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enkephalin analogues containing beta-naphthylalanine at the fourth position.
    Mierke DF; Said-Nejad OE; Schiller PW; Goodman M
    Biopolymers; 1990 Jan; 29(1):179-96. PubMed ID: 2158358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium and biological activity of oxytocin analogues modified on aromatic ring of amino acid in position 2.
    Slaninová J; Maletínská L; Vondrásek J; Procházka Z
    J Pept Sci; 2001 Aug; 7(8):413-24. PubMed ID: 11548057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule.
    Kowalczyk W; Prahl A; Derdowska I; Sobolewski D; Olejnik J; Zabrocki J; Borovicková L; Slaninová J; Lammek B
    J Med Chem; 2006 Mar; 49(6):2016-21. PubMed ID: 16539389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.